Ligand Reports Fourth Quarter and Full Year 2018 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2018 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 289.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.74 | 52 Week High | $139.79 | |||
| Open | $289.74 | 52 Week Low | $82.07 | |||
| Day High | $289.74 | P/E | 673.81 | |||
| Day Low | $289.74 | EPS | $0.43 | |||
| Volume | 1,697 | |||||

